To assess the benefits and harms of clevudine versus placebo, no intervention, or any of the nucleoside/nucleotide analogues, in people with chronic HBV infection.
This is a protocol.
Clevudine in people with chronic hepatitis B virus infection
You may also be interested in:
- Interferon for people with lamivudine-resistant chronic hepatitis B virus infection
- Interferon alpha for patients with chronic hepatitis D
- Interferon alpha versus any other drug for chronic hepatitis D
- Glycyrrhizin for chronic hepatitis B virus infection
- Phyllanthus species for chronic hepatitis B virus infection
Health topics: